Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Internal Medicine|August 4, 2014
Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centersAntonio Tursi, Walter Elisei, Marcello Picchio, et al.
European Journal of Internal Medicine|March 18, 2014
Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centresAntonio Tursi, Walter Elisei, Marcello Picchio, et al.
Journal of Clinical Gastroenterology|September 14, 2016
Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the ColonAntonio Tursi, Paola Mastromarino, Daniela Capobianco, et al.
Journal of Immunology Research|June 20, 2015
Interactions between Innate Immunity, Microbiota, and ProbioticsGianMarco Giorgetti, Giovanni Brandimarte, Federica Fabiocchi, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2021
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatientsAntonio Tursi, Giammarco Mocci, Roberto Lorenzetti, et al.
Inflammatory Bowel Diseases|May 17, 2022
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational StudyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in ItalyAntonio Tursi, Giammarco Mocci, Antonio Cuomo, et al.
Expert Opinion on Biological Therapy|February 27, 2023
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter studyGiammarco Mocci, Antonio Tursi, Giovanni Maconi, et al.
Pageof 2